Compare OpenEvidence vs PathAI

Both tools in AI Healthcare

PathAI

AI-powered digital pathology platform that automates slide analysis, biomarker quantification, and drug development support for labs and biopharma.

0 upvotesadvanced
Pricing

Pricing Comparison

OpenEvidenceOpenEvidence
Free$0

Full access for verified US clinicians, funded by pharmaceutical ads

Enterprise$Custom

Epic EHR integration and health system-wide deployment

PathAIPathAI
Enterprise$Custom

Annual licensing, cloud infrastructure, algorithm modules

Biopharma$Custom

Companion diagnostic development, clinical trial services, data licensing

Features

Feature Comparison

OpenEvidenceOpenEvidence
Quick Consult (Rapid Answer Mode)Deep Consult (Multi-Source Synthesis)Inline Journal CitationsNEJM and JAMA Content PartnershipAMA and NCCN Guideline AccessAmbient Documentation (Visits)HIPAA-Compliant Doctor DialerICD-10 and Coding IntelligenceLock Screen and Home Screen WidgetsiOS and Android Native AppsWeb Interface AccessEpic EHR Integration (Sutter Health)Evidence Search in Natural LanguageVerified Clinician-Only AccessSOC 2 Type II CertifiedPharmaceutical Ad-Funded Free Access20M+ Monthly Clinical Consultations
PathAIPathAI
AISight Digital Pathology PlatformWhole Slide Image ManagementAI Tumor Detection AlgorithmsBiomarker Quantification (PD-L1, HER2)MASH AI Assist (FDA and EMA Qualified)Companion Diagnostic DevelopmentPrecision Pathology Network AccessPLUTO Foundation ModelExplore Biomarker Discovery SuiteLIS IntegrationCase Management AutomationRemote Consultation and AnnotationGCP and GCLP Compliant Lab ServicesFDA-Cleared AISight Dx PlatformClinical Trial Patient StratificationReal-World Data MonetizationPathologist Network (450+ contributors)
Fit

Best For & Not For

OpenEvidenceOpenEvidence
✅ Best For
Verified US physicians, residents, NPs, and PAs who need instant, cited answers to clinical questions during hospital rounds, ED shifts, or primary care visits without the cost of UpToDate. Clinicians who want an AI-native alternative to manual PubMed or guideline searches, especially in time-pressured settings.
❌ Not For
Patients or non-clinicians without verified healthcare credentials, as OpenEvidence requires professional verification. Clinicians who need differential diagnosis generation or advanced drug dosing calculators, as those features are not yet available in the core platform.
PathAIPathAI
✅ Best For
Anatomic pathology laboratories at academic medical centers, reference labs, and health systems looking to digitize workflows and deploy AI-powered diagnostic algorithms. Biopharma companies developing companion diagnostics, conducting clinical trials, or seeking AI-assisted biomarker discovery using validated pathology datasets.
❌ Not For
Individual clinicians or small outpatient practices without pathology laboratory operations. Organizations seeking ambient documentation or clinical note generation rather than digital pathology image analysis and drug development tools.
Availability

Platform & Accessibility

OpenEvidenceOpenEvidence
web-basedmobile
PathAIPathAI
web-basedapi
Use & Audience

Tasks & Who It's For

OpenEvidenceOpenEvidence
Who it's for
PathAIPathAI
Who it's for
Integrations

Integrations

OpenEvidenceOpenEvidence
Other
EpicNEJMJAMAAMA
PathAIPathAI
Other
Quest Diagnostics LISLabcorp LISPaigeVisiopharm
Use Cases

Real-world Use Cases

OpenEvidenceOpenEvidence
1
Dr. Nguyen, a hospitalist on call at 2 AM, uses OpenEvidence to quickly check the latest evidence on anticoagulation dosing for a patient with atrial fibrillation and severe renal impairment, getting a cited answer in 8 seconds instead of searching three reference tools.
2
A third-year internal medicine resident uses Deep Consult before attending rounds to synthesize all current evidence on immune checkpoint inhibitor toxicity management, arriving with structured answers that impress her attending and reduce rounds time by 20 minutes.
3
An NP in a rural clinic without an UpToDate subscription uses OpenEvidence as her daily clinical reference, getting the same evidence quality for free and reducing the number of specialist referrals by consulting guidelines in real time.
PathAIPathAI
1
A reference lab pathologist reviews 80 cases per day with AISight's AI-flagged priority queue, focusing attention on the highest-risk slides first and reducing average sign-out time by 35%.
2
A biopharma data scientist uses PathAI's Explore biomarker discovery suite to identify a novel spatial biomarker in a pancreatic cancer dataset of 12,000 slides that predicts immunotherapy response, advancing a Phase 2 trial design.
3
Labcorp deploys AISight Dx across its US pathology network after its expanded PathAI partnership, enabling digital workflows for case management, slide review, and AI-assisted annotation at scale.
Keep Exploring

Similar Comparisons